Implementation of the Ogata flow cytometric scoring system in routine diagnostics of myelodysplastic syndrome-Reference-Cited by-同舟云学术

Implementation of the Ogata flow cytometric scoring system in routine diagnostics of myelodysplastic syndrome

Published:2018-09-26 Issue:11 Volume:1 Page:e90
ISSN:2398-8835
Container-title:Health Science Reports
language:en
Short-container-title:Health Sci Rep

Author:

Matzen Sara Maj Hyldig¹^ORCID,Raaschou-Jensen Klas Kraesten²³,Kallenbach Klaus⁴⁵

Affiliation:

1. Department of Clinical Biochemistry; Zealand University Hospital; Roskilde Denmark

2. Department of Haematology; Zealand University Hospital; Roskilde Denmark

3. Department of Haematology; Odense University Hospital; Odense Denmark

4. Department of Clinical Pathology; Zealand University Hospital; Roskilde Denmark

5. Department of Pathology, Rigshospitalet; Copenhagen University Hospital; Copenhagen Denmark

Publisher

Wiley

Subject

General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hsr2.90/fullpdf

Reference18 articles.

1. Myelodysplastic syndromes: 2015 update on diagnosis, risk-stratification and management;Garcia-Manero;Am J Hematol,2015

2. Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation;Wells;Blood,2003

3. A combination of CD15/CD10, CD64/CD33, CD16/CD13 or CD11b flow cytometric granulocyte panels is sensitive and specific for diagnosis of myelodysplastic syndrome;Chung;Ann Clin Lab Sci,2012

4. A multiparametric flow cytometry immunophenotypic scoring system for the diagnosis and prognosis of myelodysplastic syndromes;Huang;Clin Lab,2012

5. Improving the differential diagnosis between myelodysplastic syndromes and reactive peripheral cytopenias by multiparametric flow cytometry: the role of B-cell precursors;Reis-Alves;Diagn Pathol,2015

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Flow cytometry in the differential diagnosis of myelodysplastic neoplasm with low blasts and cytopenia of other causes;Pathology and Oncology Research;2024-07-08

2. Bone marrow S-phase is Associated with Risk assessment and Shows Differential Correlation with levels of CD34⁺Blasts and CD16⁻Granulocytes in Patients with Myelodysplastic syndromes;2024-06-07

3. Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issues;Cytometry Part B: Clinical Cytometry;2022-12-20

4. Integration of the Ki-67 proliferation index into the Ogata score improves its diagnostic sensitivity for low-grade myelodysplastic syndromes;Leukemia Research;2022-02

5. The diagnostic and prognostic significance of flow cytometric bone marrow assessment in myelodysplastic syndromes according to the European LeukemiaNet recommendations in single‐centre real‐life experience;Scandinavian Journal of Immunology;2021-02-22